Gedeon Richter - PregLem S.A.
Juan Alberto Sanchez Sepulveda has extensive experience in the pharmaceutical industry, currently working as a visitador medico at Gedeon Richter - PregLem S.A. since March 2016, where responsibilities include launching research and development products for gynecology aimed at improving quality of life through innovative molecules. Prior to this role, Juan Alberto was also a visitador medico, focusing on intelligent products that enhance individuals' quality of life. During a career spanning over two decades, Juan Alberto worked at Bayer from September 1993 to October 2015 and is currently completing a career transition course. Educational credentials include a degree in Mercadeo y Ventas from UNIANDINA (2013-2015) and an Intermediate B1 certification in English from ABA English.
This person is not in any offices
Gedeon Richter - PregLem S.A.
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.